In this context, to rule out the possibility that only PD-L1-expressing tumor cells contributed to sPD-L1 levels in peripheral blood, we examined postoperative plasma sPD-L1 levels in patients who underwent radical surgery including lobectomy or segmentectomy and lymph node dissection (n = 61) (Supplementary Table 1). The gene discussed is CD274; the disease is neoplasm.